Crossmark

Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity

Crossref DOI link: https://doi.org/10.15252/embr.202152447

Published Online: 2021-06-18

Published Print: 2021-08-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Chauveau, Lise https://orcid.org/0000-0002-2671-4488
Bridgeman, Anne

Tan, Tiong K

Beveridge, Ryan

Frost, Joe N

Rijal, Pramila

Pedroza‐Pacheco, Isabela

Partridge, Thomas

Gilbert‐Jaramillo, Javier

Knight, Michael L

Liu, Xu

Russell, Rebecca A

Borrow, Persephone https://orcid.org/0000-0002-3877-9780
Drakesmith, Hal

Townsend, Alain R

Rehwinkel, Jan https://orcid.org/0000-0003-3841-835X
Funding

Funding for this research was provided by:

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (AI00645)

Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (AI144371)

Biotechnology and Biological Sciences Research Council (BB/M011224/1)
License Information

Version of Record valid from 2021-06-18
More Information

Publication History

Received: 2021-01-12

Accepted: 2021-05-26

Published: 2021-06-18